会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • SEMI-SOLID COMPOSITIONS AND PHARMACEUTICAL PRODUCTS
    • 半固体组合物和药物产品
    • WO2010142457A1
    • 2010-12-16
    • PCT/EP2010/003532
    • 2010-06-11
    • PHOTOCURE ASASTENSRUD, Gry
    • STENSRUD, Gry
    • A61K31/195A61K9/06A61K47/10A61K47/14A61K47/44
    • A61K31/221A61K9/0031A61K9/0034A61K9/06A61K31/195A61K41/0061A61K47/10A61K47/12A61K47/14A61K47/24A61K47/26
    • This invention relates to semi-solid compositions and semi-solid pharmaceutical products for use in the photodynamic treatment (PDT) of cancer, pre-cancerous conditions and non-cancerous conditions in the female reproductive system, the anus and the penis, preferably for use in PDT of endometrial, cervical, vulvar, vaginal, anal and penile dysplasia and HPV infections of the uterus, cervix, the vulva, the vagina, the anus and the penis. The semi-solid compositions and pharmaceutical products comprise an active ingredient which is 5-aminolevulinic acid (5-ALA) or a precursor or derivative of 5-ALA or pharmaceutically acceptable salts thereof. The invention relates further to methods of PDT of cancer, pre-cancerous conditions and non-cancerous conditions in the female reproductive system, the anus and the penis, wherein said semi-solid compositions and pharmaceutical products are used.
    • 本发明涉及用于癌症的光动力学治疗(PDT),女性生殖系统,肛门和阴茎中的癌前病症和非癌症状态的半固体组合物和半固体药物产品,优选使用 在子宫内膜,子宫颈,外阴,阴道,肛门和阴茎发育异常和子宫,子宫颈,外阴,阴道,肛门和阴茎的HPV感染的PDT中。 半固体组合物和药物产品包含5-氨基乙酰丙酸(5-ALA)或5-ALA的前体或衍生物的活性成分或其药学上可接受的盐。 本发明还涉及在雌性生殖系统,肛门和阴茎中的癌症的PDT,癌前病症和非癌症病症的方法,其中使用所述半固体组合物和药物产品。
    • 8. 发明公开
    • SEMI-SOLID COMPOSITIONS AND PHARMACEUTICAL PRODUCTS COMPRISING 5-AMINOLEVULINIC ACID ESTERS
    • 哈伯斯特ZUSAMMENSETZUNGEN ARZNEIPRODUKTE ENTHALTEND ESTER DER 5-AMINOLÄVULINSÄURE
    • EP3042647A1
    • 2016-07-13
    • EP16156371.3
    • 2010-06-11
    • Photocure ASA
    • STENSRUD, Gry
    • A61K9/00A61K31/195A61K9/06A61K47/10A61K47/12A61K47/24A61K47/26A61K47/14A61K31/221
    • This invention relates to water-free, semi-solid pharmaceutical products which comprise an active ingredient selected from a 5-ALA ester and pharmaceutically acceptable salts thereof; one or more triglycerides; and optionally one or more viscosity enhancers; wherein the concentration of the active ingredient is 0.5 to 30% by weight of the total weight of the product, and the concentration of the one or more triglycerides is in the range of 60 to 96% by weight of the total weight of the product if the one or more viscosity enhancers are present, or in the range of 70 to 99.5% by weight of the total weight of the product if the one or more viscosity enhancers are not present. The invention further relates to the use of such products in the photodynamic treatment (PDT) of cancer, pre-cancerous conditions and non-cancerous conditions in the female reproductive system, the anus and the penis, preferably in PDT of endometrial, cervical, vulvar, vaginal, anal and penile dysplasia and HPV infections of the uterus, cervix, the vulva, the vagina, the anus and the penis.
    • 本发明涉及无水半固体药物产品,其包含选自5-ALA酯和其药学上可接受的盐的活性成分; 一种或多种甘油三酯; 和任选的一种或多种粘度增强剂; 其中所述活性成分的浓度为所述产品总重量的0.5至30重量%,并且所述一种或多种甘油三酯的浓度在产物总重量的60至96重量%的范围内,如果 如果不存在一种或多种粘度增强剂,则存在一种或多种粘度增强剂,或者在产品总重量的70-99.5重量%的范围内。 本发明还涉及这种产品在女性生殖系统,肛门和阴茎中的癌症,癌前病症和非癌症状态的光动力学治疗(PDT)中的应用,优选在子宫内膜,宫颈,外阴的PDT中 阴道,肛门和阴茎发育不良以及子宫,子宫颈,外阴,阴道,肛门和阴茎的HPV感染。